Skip to main content

Table 1 Clinicopathological characteristics of the 227 patients with stage II colorectal carcinoma included in this study

From: Prognostic significance of MUC2, CDX2 and SOX2 in stage II colorectal cancer patients

  Frequency (n) Percentage (%)
Patients 227  
Age (years)  
 Media 68.3 ± 11.5
 Range 23–92
Sex
 Female 92 40.5
 Male 135 59.5
Histopathological grade
 G1 4 1.8
 G2 210 93.7
 G3 10 4.5
 Mucinous 3  
Tumor Location
 Proximal colon 75 33.5
 Distal colon 107 47.8
 Rectum 42 18.7
 ND 3  
Chemotherapy
 Neo-Adjuvant
 Yes 11 4.8
 No 216 95.2
Adjuvant
 Yes 34 15.4
 No 187 84.6
 ND 6  
Resection margins
 R0 179 98.9
 R1/R2 2 1.1
 ND 46  
BRAF V600E
 WT 186 86.1
 MUT 30 13.9
 ND 11  
Mismatch repair status
 MMR-deficient 91 43.5
 MMR-proficient 118 56.5
 ND 18  
\